BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6297 related articles for article (PubMed ID: 3132176)

  • 21. Phenol and catechol induce prehemolytic and hemolytic changes in human erythrocytes.
    Bukowska B; Kowalska S
    Toxicol Lett; 2004 Aug; 152(1):73-84. PubMed ID: 15294349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of catechol on human peripheral blood mononuclear cells (in vitro study).
    Bukowska B; Michałowicz J; Marczak A
    Environ Toxicol Pharmacol; 2015 Jan; 39(1):187-93. PubMed ID: 25528409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tyrosinase-catalyzed oxidation of dopa and related catechol(amine)s: a kinetic electron spin resonance investigation using spin-stabilization and spin label oximetry.
    Korytowski W; Sarna T; Kalyanaraman B; Sealy RC
    Biochim Biophys Acta; 1987 Jun; 924(3):383-92. PubMed ID: 3036239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective toxicity of 5-S-cysteinyldopa, a melanin precursor, to tumor cells in vitro and in vivo.
    Fujita K; Ito S; Inoue S; Yamamoto Y; Takeuchi J; Shamoto M; Nagatsu T
    Cancer Res; 1980 Jul; 40(7):2543-6. PubMed ID: 6771000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemical properties of catechols and their molecular modes of toxic action in cells, from microorganisms to mammals.
    Schweigert N; Zehnder AJ; Eggen RI
    Environ Microbiol; 2001 Feb; 3(2):81-91. PubMed ID: 11321547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement by catechols of hydroxyl-radical formation in the presence of ferric ions and hydrogen peroxide.
    Iwahashi H; Morishita H; Ishii T; Sugata R; Kido R
    J Biochem; 1989 Mar; 105(3):429-34. PubMed ID: 2543661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catechol cytotoxicity in vitro: induction of glioblastoma cell death by apoptosis.
    de Oliveira DM; Pitanga BP; Grangeiro MS; Lima RM; Costa MF; Costa SL; Clarêncio J; El-Bachá RS
    Hum Exp Toxicol; 2010 Mar; 29(3):199-212. PubMed ID: 20097727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conjugation of dopa and 5-S-cysteinyldopa with cysteine mediated by superoxide radical.
    Ito S; Fujita K
    Biochem Pharmacol; 1982 Sep; 31(18):2887-9. PubMed ID: 6291549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of L-dopa on the potentiation of radiation damage to human melanoma cells.
    Yamada I; Seki S; Ito S; Suzuki S; Matsubara O; Kasuga T
    Br J Cancer; 1990 Jul; 62(1):33-6. PubMed ID: 2390479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective toxicity of deoxyadenosine analogues in human melanoma cell lines.
    Parsons PG; Bowman EP; Blakley RL
    Biochem Pharmacol; 1986 Nov; 35(22):4025-9. PubMed ID: 2430574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopa oxidation and tyrosine oxygenation by human melanoma tyrosinase.
    Jergil B; Lindbladh C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1983; 63(6):468-75. PubMed ID: 6198834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A selective de-O-methylation of guaiacyl lignans to corresponding catechol derivatives by 2-iodoxybenzoic acid (IBX). The role of the catechol moiety on the toxicity of lignans.
    Bernini R; Barontini M; Mosesso P; Pepe G; Willför SM; Sjöholm RE; Eklund PC; Saladino R
    Org Biomol Chem; 2009 Jun; 7(11):2367-77. PubMed ID: 19462048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The inherent cytotoxicity of melanin precursors: a revision.
    Urabe K; Aroca P; Tsukamoto K; Mascagna D; Palumbo A; Prota G; Hearing VJ
    Biochim Biophys Acta; 1994 Apr; 1221(3):272-8. PubMed ID: 8167148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of halogenated substituents on the metabolism and estrogenic effects of the equine estrogen, equilenin.
    Liu X; Zhang F; Liu H; Burdette JE; Li Y; Overk CR; Pisha E; Yao J; van Breemen RB; Swanson SM; Bolton JL
    Chem Res Toxicol; 2003 Jun; 16(6):741-9. PubMed ID: 12807357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COMT-dependent protection of dopaminergic neurons by methionine, dimethionine and S-adenosylmethionine (SAM) against L-dopa toxicity in vitro.
    Werner P; Di Rocco A; Prikhojan A; Rempel N; Bottiglieri T; Bressman S; Yahr MD
    Brain Res; 2001 Mar; 893(1-2):278-81. PubMed ID: 11223018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibroblasts that express aromatic amino acid decarboxylase have increased sensitivity to the synergistic cytotoxicity of L-dopa and manganese.
    Montine TJ; Underhill TM; Linney E; Graham DG
    Toxicol Appl Pharmacol; 1994 Sep; 128(1):116-22. PubMed ID: 8079344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tyrosinase activity in the medium of human melanoma cell cultures.
    Jergil B; Lindbladh C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1983; 63(3):205-8. PubMed ID: 6192632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbonyl side-chain of catechol compounds is a key structure for the suppression of copper-associated oxidative DNA damage in vitro.
    Ando M; Nishida H; Nishino Y; Ohbayashi M; Ueda K; Okamoto Y; Kojima N
    Toxicol Lett; 2010 Dec; 199(3):213-7. PubMed ID: 20832456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of conventional and sustained delivery of levodopa on SH-SY5Y neuroblastoma cells.
    Martin TM; Benghuzzi H; Tucci M
    Biomed Sci Instrum; 2005; 41():382-7. PubMed ID: 15850136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radical sequestration by protein-bound 3,4-dihydroxyphenylalanine.
    Nelson M; Foxwell AR; Tyrer P; Dean RT
    Int J Biochem Cell Biol; 2010 May; 42(5):755-61. PubMed ID: 20083224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 315.